SPC283
Talazóparíb, mögulega á formi lyfjafræðilega viðunandi salts
Status:
VeittApplication date:
21.11.2019Application published:
15.12.2019Grant published:
15.9.2020
Max expiry date:
23.6.2034Medicine name:
TalzennaMedicine for children:
No
Timeline
Today
21.11.2019Application
15.12.2019Publication
15.9.2020Registration
23.6.2034Expires
Marketing license
IS authorization number:
EU/1/19/1377/001-004; EU/1/19/1377/005-006Date:
16.7.2019
Foreign authorization number:
EU/1/19/1377Date:
20.6.2019
Owner
Name:
Medivation Technologies LLCAddress:
66 Hudson Boulevard East, New York, NY 10001-2192 US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2767537